Journal article
Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion The COMPASS-CABG Study
Abstract
BACKGROUND: Patients with recent coronary artery bypass graft (CABG) surgery are at risk for early graft failure, which is associated with a risk of myocardial infarction and death. In the COMPASS (Cardiovascular OutcoMes for People Using Anticoagulation StrategieS) trial, rivaroxaban 2.5 mg twice daily plus aspirin 100 mg once daily compared with aspirin 100 mg once daily reduced the primary major adverse cardiovascular events (MACE) outcome …
Authors
Lamy A; Eikelboom J; Sheth T; Connolly S; Bosch J; Fox KAA; Zhu J; Lonn E; Dagenais G; Widimsky P
Journal
Journal of the American College of Cardiology, Vol. 73, No. 2, pp. 121–130
Publisher
Elsevier
Publication Date
1 2019
DOI
10.1016/j.jacc.2018.10.048
ISSN
0735-1097